About the Education Program: Digital Select

About the Education Program: Digital Select

About the Education Program: AES 2024 Digital Select

 

Statement of Need

The need for this activity has been determined based on identifying professional practice gaps, previous course evaluations, and AES self-assessments. The educational content of this activity was based upon current issues and topics provided by the AES Annual Meeting Committee and membership.

 

Target Audience

Neurologists, epileptologists, pediatric neurologists, nurses, psychologists, neuropsychologists, nurse practitioners, physician assistants, pharmacists, researchers, and scientists.

 

Global Learning Objectives

This comprehensive educational meeting provides learners with opportunities to: 

  • Increase knowledge about the diagnosis and treatment, including novel diagnostic methods and therapeutic modalities of, various manifestations of epilepsy and common comorbidities to enhance clinical practice and improve patient outcomes. 
  • Be informed about the latest research developments in epilepsy that may translate into clinical care and human therapy in the near future. 
  • Consider the public health implications of epilepsy and the impact of the disease on patients, communities, and health systems. 

 

Each session has its own specific learning objectives, which can be found in the program.

Mission Statement

The American Epilepsy Society (AES) promotes research and education for physicians and other healthcare professionals dedicated to the prevention, treatment, and cure of epilepsy. Its continuing professional education (CPE) offers an array of activities to assist the learner in assessing their educational needs and expanding their knowledge, competence, and performance in the field of epilepsy, which leads to an improvement in the outcomes of care. 

The CPE program always reinforces the fundamental components of epilepsy care in accordance with an Epilepsy Core Curriculum, including quality improvement and patient safety. In addition, its educational interventions also provide an opportunity to advance professional practice in new and emerging areas of the specialty. In recognition of the importance of the added qualification in epilepsy by the American Board of Psychiatry and Neurology as well as the Maintenance of Certification requirements, AES is committed to the provision of educational opportunities and tools that aid in the certification and MOC requirements. 

 

The expected results of the AES program of continuing professional development are as follows:

  • The AES CPE Program fosters a culture of interprofessional collaboration amongst the cadre of professionals who care for persons with epilepsy.
  • The AES CPE Program enhances the professional practice of healthcare professionals who care for persons with epilepsy.
  • The AES CPE Program provides education in epilepsy therapy to increase the competence of clinicians in the use of these complex and multi-layered options to manage epilepsy in patients.
  • The AES CPE Program uses educational interventions as a tool to improve the quality of care and patient safety of persons with epilepsy.

 

Accreditation

This enduring activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education. The American Epilepsy Society (AES) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

 

AMA PRA Category 1 Credit™ Designation

AES designates this enduring activity for a maximum of 55.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

International Credits

The American Medical Association has determined that non-US licensed physicians who participate in this CME activity are eligible for AMA PRA Category 1 Credits™.

 

Physician Assistants

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 55.25 hours of Category 1 credit for completing this program.

 

Continuing Education for Nurses and Pharmacists

Amedco Logo

In support of improving patient care, this activity has been planned and implemented by the American Epilepsy Society and Amedco. In support of improving patient care, Amedco is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. 

Amedco Joint Accreditation Provider Number: 4008163 

 

Pharmacists & Pharmacy Technicians 

Amedco LLC designates this activity for a maximum of 41.75 knowledge-based CPE contact hours. 

NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior. 

 

Nurses 
Amedco LLC designates this activity for a maximum of 55.25 ANCC contact hours. 


Continuing Certification

The American Board of Psychiatry and Neurology accepts AMA PRA Category 1 CME Credits™.  The CME credits earned from the AES 2024 Annual Meeting may be applied toward your ABPN CME requirement. 

Disclosure Policy and Resolution of Conflicts of Interest

It is the policy of the American Epilepsy Society to ensure balance, independence, objectivity, and scientific rigor. All individuals involved in the selection, development, and presentation of content are required to disclose any real or apparent conflicts of interest. Conflicts of interest will be resolved by AES prior to an educational activity being delivered to learners. In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, AES requires that any person who is in a position to control content of a CME activity must disclose all relevant financial relationships that they have with an ineligible company. AES has implemented the mechanisms of prospective peer review of this CME activity to identify and resolve any conflicts. Additionally, the content of this activity is based on the best available evidence.  

Planner and faculty disclosures can be found here.

 

Unapproved Use Disclosure

The American Epilepsy Society requires CME authors to disclose to learners when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved) and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information. Information about pharmaceutical agents/devices that is outside of U.S. Food and Drug Administration approved labeling may be contained in this activity.  

 

Disclaimer

This CME activity is for educational purposes only and does not constitute the opinion or endorsement of, or promotion by, the American Epilepsy Society. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label, investigational, and/or experimental uses. 

 

Content Categories 

Basic: Those new to epilepsy treatment or whose background in the specialty is limited, e.g., students, residents, general physicians, general neurologists, neurosurgeons, other professionals in epilepsy care, and administrators. 

Intermediate: Epilepsy fellows, epileptologists, epilepsy neurosurgeons, and other providers with experience in epilepsy care (i.e., advanced practice nurses, nurses, and physician assistants), neuropsychologists, psychiatrists, and basic and translational researchers. 

Advanced: Address highly technical or complex topics (e.g., neurophysiology, advanced imaging techniques or advanced treatment modalities, including surgery).  

 

 

AES Annual Meeting Session Types

Annual Course: Encourages in-depth exploration of important topics related to epilepsy, focused on clinical care, including review of the science underlying the topics, reviews of clinical research, and discussion of the associated clinical implications. The Annual Course includes a mixture of educational lectures, clinical vignettes, and panel discussions.

Basic Science Skills Workshops: Deliver learning opportunities on basic science research techniques and methodologies. Attendees will learn about approaches and applications they can incorporate into their own research. Included in meeting registration fee.

Clinical Skills Workshops: Deliver hands-on and interactive learning opportunities in focused clinical areas. Attendance at each workshop is limited to a small number of participants to allow optimal interaction. Advance registration and an additional fee are required.

Dialogues to Transform Epilepsy: This session introduces transformative neurobiological research from outside the epilepsy field, with discussions on how those advances could accelerate progress in epilepsy.

Epilepsy Fellowship Program Directors Meeting: Provides a forum for current clinical epilepsy program directors, clinical neurophysiology program directors, and those interested in starting an ACGME Fellowship, to address challenges in running a program and meeting accreditation requirements. This session will meet ACGME program requirement II.A.4.

Investigators Workshops (IW): Highlight exciting developments in basic, translational, and clinical epilepsy research in a format promoting interactive discussion. Speakers include established and junior epilepsy investigators, as well as researchers from other fields.

Poster Sessions: Posters are grouped by general topic category at various times throughout the meeting. Poster authors are available for discussion during each session. Check the program for author present times. In addition, the following special poster sessions offer additional times to interact with authors:

Poster Walking Tours: Tours of selected posters led by leading experts in topic areas.

Basic Science Poster Session: This session features the most exciting and innovative studies focused on understanding the basic mechanisms of epilepsy and using cutting-edge approaches to understand and treat the mechanisms of epilepsy.

Platform Sessions: Three concurrent sessions highlighting selected key scientific abstracts consisting of author presentations followed by Q&A.

Pediatric Epilepsy Highlight Session: This session showcases scientific abstracts focused on topics in clinical care and research in pediatric epilepsy.

Broadening Representation Inclusion and Diversity by Growing Equity (BRIDGE): This session spotlights research relating to the needs of underserved populations along with showcasing the work of accomplished investigators who identify with groups historically underrepresented in medicine and research.

Professional Development: Offers mentorship, training, and information geared to early career professionals or anyone considering a career change.

Special Interest Groups (SIG): Offer information and networking for attendees with similar interests, in sessions organized by AES members. Although the sizes of SIG sessions vary, all lend themselves to active participation and dialogue.

Special Lectures: Recognize the accomplishments of distinguished leaders in clinical epilepsy and research and/or highlight current developments in the field.

Symposia: Provide the major educational activities at the Annual Meeting. Topics range from clinically oriented presentations reviewing common issues in epilepsy to more complex topics combining basic sciences and clinical neurology. While target audiences differ, all symposia include discussion

 

 


 

Commercial Support of Accredited Medical Education 

22nd Judith Hoyer Lecture in Epilepsy | Treating Seizure Patterns: Past, Present and Future  
This educational activity is supported in part by an education grant from Upsher-Smith Laboratories, LLC 

Advanced Practice Providers Symposium | Standing in the Gap: How Can APPs Address Health Disparities in People with Epilepsy?  
This educational activity is supported in part by an education grant from Neurelis Inc. 

Merritt-Putnam Symposium | Developmental and Epileptic Encephalopathies - Current Concepts and Novel Approaches 
This educational activity is supported in part by education grants from Jazz Pharmaceuticals, Inc. and UCB, Inc.  

Presidential Symposium | Imaging Epilepsy: Past, Passing, and to Come  
This educational activity is supported in part by an education grant from Jazz Pharmaceuticals, Inc. 

Pediatric State of the Art Symposium | Mobilizing a New Era in Lennox-Gastaut Syndrome Treatment and Prevention 
This educational activity is supported in part by education grants from Jazz Pharmaceuticals, Inc., Marinus Pharmaceuticals, Inc. and UCB, Inc.  

Epilepsy Therapies Symposium | Latest and Future Development of Epilepsy Therapeutics  
This educational activity is supported in part by an education grant from UCB, Inc.  

SIG | Neonatal Seizures: Seizures and Neuromonitoring in Pre-term Infants 
This educational activity is supported in part by an education grant from Upsher-Smith Laboratories, LLC 

SIG | Tuberous Sclerosis Complex: Clinical Trials for Epilepsy TSC – Lessons Learned and Future Perspectives 
This educational activity is supported in part by an education grant from Upsher-Smith Laboratories, LLC 

SIG | Psychosocial Comorbidities: Psychosocial Burden and Suicidality in Epilepsy 
This educational activity is supported in part by an education grant from Xenon Pharmaceuticals Inc. 

SIG | Clinical Epilepsy for the Advanced Practice Provider: Filling the Gap in Mental Health Care 
This educational activity is supported in part by education grants from LivaNova and Xenon Pharmaceuticals Inc. 

SIG | Neuropsychology: Integrating Technology into Epilepsy Neuropsychology 
This educational activity is supported in part by an education grant from Xenon Pharmaceuticals Inc.